Oxford Nanopore Technologies PLC

ONT

Equity

ISIN GB00BP6S8Z30 / Valor 23783705

LSE London Stock Exchange, SETS (2026-10-30)

GBP 2.23-4.63%

Oxford Nanopore Technologies PLC
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Oxford Nanopore Technologies plc is a UK-based, publicly traded life sciences company that develops and sells nanopore-based DNA and RNA sequencing platforms, consumable flow cells and reagents, and supporting software and services. Its product range spans portable devices for field and point-of-care use (e.g., MinION and Flongle), benchtop systems (GridION) and higher-throughput instruments (PromethION), and the company emphasizes long-read and direct RNA sequencing capabilities and real‑time data analysis. Customers include academic and clinical researchers, public‑health agencies, and industrial users in areas such as genomics, infectious‑disease surveillance, agriculture and bioprocessing; the company’s revenue mix combines instrument sales with recurring consumables, reagents and software/service offerings. Founded in Oxford in 2005, the business has focused on scaling commercial adoption while continuing R&D and regulatory work to expand clinical and diagnostic applications.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

63.1%1Y

7.95%3Y

-59.9%5Y

Performance

58.4%1Y

59.1%3Y

58.3%5Y

Volatility